|
1
|
Yabut SM Jr, Kenan S, Sissons HA and Lewis
MM: Malignant transformation of fibrous dysplasia. A case report
and review of the literature. Clin Orthop Relat Res. (228):
281–289. 1988.
|
|
2
|
Ruggieri P, Sim FH, Bond JR and Unni KK:
Malignancies in fibrous dysplasia. Cancer. 73:1411–1424. 1994.
|
|
3
|
Hoshi M, Matsumoto S, Manabe J, Tanizawa
T, Shigemitsu T, Izawa N, Takeuchi K and Kawaguchi N: Malignant
change secondary to fibrous dysplasia. Int J Clin Oncol.
11:229–235. 2006.
|
|
4
|
Doganavsargil B, Argin M, Kececi B, Sezak
M, Sanli UA and Oztop F: Secondary osteosarcoma arising in fibrous
dysplasia, case report. Arch Orthop Trauma Surg. 129:439–444.
2009.
|
|
5
|
Riminucci M, Robey PG, Saggio I and Bianco
P: Skeletal progenitors and the GNAS gene: fibrous dysplasia of
bone read through stem cells. J Mol Endocrinol. 45:355–364.
2010.
|
|
6
|
Liang Q, Wei M, Hodge L, Fanburg-Smith JC,
Nelson A, Miettinen M, Foss RD and Wang G: Quantitative analysis of
activating alpha subunit of the G protein (Gsα) mutation by
pyrosequencing in fibrous dysplasia and other bone lesions. J Mol
Diagn. 13:137–142. 2011.
|
|
7
|
Tabareau-Delalande F, Collin C,
Gomez-Brouchet A, Decouvelaere AV, Bouvier C, Larousserie F, Marie
B, Delfour C, Aubert S, Rosset P, de Muret A, Pagès JC and de
Pinieux G: Diagnostic value of investigating GNAS mutations in
fibro-osseous lesions: a retrospective study of 91 cases of fibrous
dysplasia and 40 other fibro-osseous lesions. Mod Pathol.
26:911–921. 2013.
|
|
8
|
Gu W, Ogose A, Matsuba A, Kawashima H,
Hotta T, Kudo N, Hoshino M, Kondo N, Mera H and Endo N: Activating
Gs a mutation rarely occurs in musculoskeletal tumors other than
fibrous dysplasia. Anticancer Res. 26(2B): 1611–1614. 2006.
|
|
9
|
DiCaprio MR and Enneking WF: Fibrous
dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint
Surg Am. 87:1848–1864. 2005.
|
|
10
|
Siegal GP, Bianco P and Dal Cin P: Fibrous
dysplasia. WHO Classification of Tumours of Soft Tissue and Bone.
Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: 4th edition.
International Agency for Research on Cancer; Lyon, France: pp.
352–353. 2013
|
|
11
|
Gorlick R and Khanna C: Osteosarcoma. J
Bone Miner Res. 25:683–691. 2010.
|
|
12
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: a
review. Sarcoma 2011. 2011:9592482011.
|
|
13
|
Rosenberg AE, Cleton-Jansen A-M, de
Pinieux G, Deyup AT, Hauben E and Squire J: Conventional
osteosarcoma. WHO Classification of Tumours of Soft Tissue and
Bone. Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: 4th
edition. International Agency for Research on Cancer; Lyon, France:
pp. 282–288. 2013
|
|
14
|
Bridge JA, Nelson M, McComb E, McGuire MH,
Rosenthal H, Vergara G, Maale GE, Spanier S and Neff JR:
Cytogenetic findings in 73 osteosarcoma specimens and a review of
the literature. Cancer Genet Cytogenet. 95:74–87. 1997.
|
|
15
|
Martin JW, Squire JA and Zielenska M: The
genetics of osteosarcoma. Sarcoma. 2012:6272542012.
|
